SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Sep. 12, 2019--
Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company, announced today the launch of an educational website for healthcare providers. The website, https://metabolicacidosisinsights.com, is an online resource providing essential information about metabolic acidosis in patients with chronic kidney disease (CKD), including the underlying pathophysiology of the condition, and its clinical consequences, including progression of CKD.
The website also features video discussions from prominent physicians as well as a real-world example of the impact of the disease on patients’ lives. Importantly, the website offers additional valuable references from peer reviewed journals.
“Chronic metabolic acidosis in patients with CKD is a serious condition that needs to be treated,” stated Navdeep Tangri, MD, PhD, Associate Professor of Medicine, Department of Medicine and Community Health Sciences and Scientific Director of the Chronic Disease Innovation Center, University of Manitoba and a consultant to Tricida. “Recent real-world research by my group and others shows that metabolic acidosis is currently underdiagnosed and undertreated, highlighting the need to raise awareness of its serious consequences, which include bone loss, muscle wasting, early mortality and accelerated progression of CKD.”
Learn more about metabolic acidosis in patients with CKD at https://metabolicacidosisinsights.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190912005534/en/
Source: Tricida, Inc.
Jackie Cossmon, IRC
Vice President of Investor Relations and Communications